Niveditha Ravindra
8PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Feb 06, 2026
Whole Genome Sequencing Informed Patient Personalized Measurable Residual Disease Assays for Acute Myeloid Leukemia.Niveditha Ravindra, Justin Lack, Clifton L Dalgard
|Nov 25, 2025
Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemia.Rasha W Al-Ali, Gege Gui, Niveditha Ravindra
|Nov 06, 2024
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia.Gege Gui, Niveditha Ravindra, Pranay S Hegde
|Oct 25, 2024
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia.Gege Gui, Niveditha Ravindra, Pranay S Hegde
|Oct 18, 2024
Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia.Pranay S Hegde, Georgia Andrew, Gege Gui
|Jan 05, 2024
Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide.Niveditha Ravindra, Laura W Dillon, Gege Gui
Pageof 2
Frequent Collaborators
6 joint publications
Laura W Dillon
4 joint publications
Jeffery J Auletta
4 joint publications
Steven M Devine
4 joint publications
Antonio Martin Jimenez Jimenez
4 joint publications
Marcos J G De Lima
4 joint publications
Mark R Litzow
4 joint publications
Partow Kebriaei
3 joint publications
Christopher S Hourigan
3 joint publications
Stephen R Spellman
3 joint publications
Zoë Wong
